Hematology

A novel form of CAR T-cell therapy, engineered to enhance immune response, is showing encouraging results in patients with relapsed or refractory lymphoma who previously failed anti-CD19 CAR T-cell treatment.

A recent study has found that women with sickle cell disease experience higher inflammation during the follicular phase of their menstrual cycle, which may explain the timing of pain episodes and offer insight into more personalised care.

A retrospective analysis of global data has found that a specific treatment sequence, starting with small molecule inhibitors and followed by epigenetic modifiers, may significantly improve survival in patients with relapsed or refractory T-cell lymphomas.

A newly recognised subtype of Castleman disease (CD), termed oligocentric CD (OligoCD), has been identified and characterised through the ACCELERATE natural history registry….

A new study from the COMBI-AD trial shows that circulating tumour DNA (ctDNA) testing can accurately predict recurrence and survival in stage III melanoma, offering a potential tool for personalising treatment.

Statins may offer unexpected benefits for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

A new study introduces InflaMix, a groundbreaking tool that could transform how clinicians assess treatment risk in patients with non-Hodgkin lymphoma…

A recent trial shows that a multifaceted anaemia treatment bundle improves haemoglobin recovery in critically ill patients, enhancing recovery after surgery or critical illness.